Toggle Main Menu Toggle Search

Open Access padlockePrints

Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities

Lookup NU author(s): Professor Akane Kawamura

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2017 The Author(s). Chemokines function via G-protein coupled receptors in a robust network to recruit immune cells to sites of inflammation. Due to the complexity of this network, targeting single chemokines or receptors has not been successful in inflammatory disease. Dog tick saliva contains polyvalent CC-chemokine binding peptides termed evasins 1 and 4, that efficiently disrupt the chemokine network in models of inflammatory disease. Here we develop yeast surface display as a tool for functionally identifying evasins, and use it to identify 10 novel polyvalent CC-chemokine binding evasin-like peptides from salivary transcriptomes of eight tick species in Rhipicephalus and Amblyomma genera. These evasins have unique binding profiles compared to evasins 1 and 4, targeting CCL2 and CCL13 in addition to other CC-chemokines. Evasin binding leads to neutralisation of chemokine function including that of complex chemokine mixtures, suggesting therapeutic efficacy in inflammatory disease. We propose that yeast surface display is a powerful approach to mine potential therapeutics from inter-species protein interactions that have arisen during evolution of parasitism in ticks.


Publication metadata

Author(s): Singh K, Davies G, Alenazi Y, Eaton JRO, Kawamura A, Bhattacharya S

Publication type: Article

Publication status: Published

Journal: Scientific Reports

Year: 2017

Volume: 7

Online publication date: 27/06/2017

Acceptance date: 31/05/2017

Date deposited: 14/10/2019

ISSN (electronic): 2045-2322

Publisher: Nature Publishing Group

URL: https://doi.org/10.1038/s41598-017-04378-1

DOI: 10.1038/s41598-017-04378-1

PubMed id: 28655871


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
CH/09/003
RE/13/1/30181
Wellcome Trust

Share